Laboratory Evaluation for Facial Hirsutism
For women presenting with excess facial hair growth (hirsutism score >6 on modified Ferriman-Gallwey scale), measure total or free testosterone, DHEAS, and consider additional endocrine testing based on clinical features. 1
Essential Laboratory Tests
First-Line Hormonal Assessment
- Total testosterone or bioavailable/free testosterone: Levels >200 ng/dL suggest an androgen-secreting tumor requiring urgent imaging 1
- DHEAS (dehydroepiandrosterone sulfate): Elevated levels point toward adrenal sources of androgen excess 1
- Androstenedione: Helps differentiate between ovarian and adrenal androgen production 1
Additional Screening Tests
- TSH (thyroid-stimulating hormone): Thyroid disorders can contribute to hirsutism 2, 1
- Prolactin: Hyperprolactinemia may present with hirsutism 1, 3
- Glucose/insulin levels: Assess for insulin resistance, particularly in PCOS 1
When to Expand Laboratory Workup
Signs Requiring Full Endocrine Evaluation
The American Academy of Dermatology recommends comprehensive testing when hirsutism occurs with: 2
- Oligomenorrhea or amenorrhea (irregular or absent periods)
- Infertility
- Clitoromegaly (genital virilization)
- Truncal obesity
- Rapid onset over weeks to months (tumor concern) 3
Routine Testing NOT Recommended
- Mild hirsutism without other hyperandrogenic signs does not require endocrine testing 2
- Microbiologic testing is not indicated for hirsutism evaluation 2
Imaging Studies
Pelvic Ultrasound Indications
- Suspected PCOS: Look for >10 peripheral cysts (2-8 mm diameter) with thickened ovarian stroma 1
- Pelvic examination: Assess for adnexal masses suggesting ovarian tumors 1
When to Order CT/MRI
- Testosterone >200 ng/dL: Obtain adrenal and pelvic imaging to locate androgen-secreting tumors 1
- Markedly elevated DHEAS: Focus on adrenal imaging
Special Diagnostic Considerations
Testing for Specific Conditions
- Non-classical congenital adrenal hyperplasia: 17-hydroxyprogesterone level, particularly in women of Mediterranean, Hispanic, or Ashkenazi Jewish descent 1, 4
- Cushing syndrome: 24-hour urinary free cortisol or overnight dexamethasone suppression test if clinical features present 1
Medication History
Document use of: 1
- Exogenous androgens (testosterone, DHEA supplements)
- Certain antiepileptic drugs (valproate, phenytoin) - women with epilepsy have 10-25% prevalence of PCOS 1
- Androgenic progestins (norethisterone, levonorgestrel) 1
Clinical Assessment Components
Physical Examination Findings
- Acanthosis nigricans: Dark, velvety skin suggesting insulin resistance 1, 4
- Androgenetic alopecia: Male-pattern baldness 2, 1
- Severe acne: Particularly treatment-resistant cases 2
- Body habitus: Central obesity pattern 1
Family History
- Strong genetic component: PCOS and androgen receptor sensitivity run in families 4
- Similar symptoms in female relatives support idiopathic or PCOS-related hirsutism 1
Common Diagnostic Pitfalls
- Asian women may have normal androgen levels despite significant hirsutism due to increased 5α-reductase activity 4
- Idiopathic hirsutism (5-15% of cases) presents with normal ovulation and normal androgen levels - diagnosis of exclusion 4, 5
- PCOS accounts for 70-80% of hirsutism cases but requires only 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, or polycystic ovaries 2, 1